Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
RecruitingNCT02071134Phase: Not specifiedStarted 2014-03-04
Summary
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease.
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Neurology and Pain SpecialtyAliso Viejo, California, United States
Cedars Sinai Medical CenterLos Angeles, California, United States
University of ColoradoAurora, Colorado, United States
St. Mary's Hospital and Medical CenterGrand Junction, Colorado, United States
University of Florida Shands HospitalGainesville, Florida, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT02071134